Timothy Barberich - Jul 20, 2021 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Director
Signature
/s/ Timothy J Barberich
Stock symbol
TCRX
Transactions as of
Jul 20, 2021
Transactions value $
$0
Form type
4
Date filed
7/22/2021, 07:43 AM
Previous filing
Jul 15, 2021
Next filing
Jun 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRX Voting Common Stock Conversion of derivative security +33.3K 33.3K Jul 20, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRX Series B Preferred Stock Conversion of derivative security -33.3K -100% 0 Jul 20, 2021 Voting Common Stock 33.3K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of the Issuer's Series B Preferred Stock automatically converted on a one for one basis into Voting Common Stock immediately prior to the closing of the Issuer's initial public offering, without payment or further consideration. The preferred stock had no expiration date.